Waterfront Wealth
VRTX icon

Waterfront Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Waterfront Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.12M Sell
2,181
-13
-0.6% -$6.66K 0.18% 153
2026
Q2 		$1.06M Buy
2,194
+25
+1% +$11.1K 0.17% 162
2026
Q1 		$969K Buy
2,169
+88
+4% +$41K 0.18% 155
2025
Q4 		$985K Sell
2,081
-1
-0% -$431 0.19% 152
2025
Q3 		$886K Buy
+2,082
New +$870K 0.18% 152

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Waterfront Wealth's VRTX Position: Q3 2026 in Review

Waterfront Wealth reduced its Vertex Pharmaceuticals (VRTX) stake by 0.59% in Q3 2026, selling an estimated $6.66K and leaving 2,181 shares worth $1.12M. The position accounts for 0.18% of the portfolio, ranked #153.

Waterfront Wealth first reported a position in VRTX in Q3 2025 and has held it in 5 quarters since. 992 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Waterfront Wealth held 2,181 shares of Vertex Pharmaceuticals worth $1.12M as of Q3 2026.
  • Waterfront Wealth sold 13 Vertex Pharmaceuticals shares in Q3 2026, an estimated $6.66K.
  • Vertex Pharmaceuticals made up 0.18% of Waterfront Wealth's portfolio in Q3 2026, its #153 holding.
  • Waterfront Wealth first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 992 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Waterfront Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.